![Patrick Lamy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Patrick Lamy worked at Gilead Sciences, Inc. from 2008 to 2018 as Head-Commercial Strategy & Banking.
From 2018 to 2021, worked at Iovance Biotherapeutics, Inc. as Vice President-Commercial.
From 2023 to 2025, worked at Akero Therapeutics, Inc. as Senior Vice President-Commercial Strategy.
Education includes an MBA from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.
Eerdere bekende functies van Patrick Lamy
| Bedrijven | Functie | Einde |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 09-12-2025 |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-09-2018 |
Opleiding van Patrick Lamy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
